These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11411495)

  • 1. Determination of oral dosage and pharmacokinetic analysis of flecainide in horses.
    Ohmura H; Hiraga A; Aida H; Takahashi T; Nukada T
    J Vet Med Sci; 2001 May; 63(5):511-4. PubMed ID: 11411495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation.
    Ohmura H; Nukada T; Mizuno Y; Yamaya Y; Nakayama T; Amada A
    J Vet Med Sci; 2000 Jul; 62(7):711-5. PubMed ID: 10945288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Pharmacokinetic and Electrocardiographic Effects of Intratracheal and Intravenous Administration of Flecainide in Anesthetized Pigs.
    Stocco FG; Evaristo E; Silva AC; de Antonio VZ; Pfeiffer J; Rangachari N; Belardinelli L; Verrier RL
    J Cardiovasc Pharmacol; 2018 Sep; 72(3):129-135. PubMed ID: 29923887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs.
    Sällström J; Al-Saffar A; Pehrson R
    J Pharmacol Toxicol Methods; 2014; 69(1):24-9. PubMed ID: 24140388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and electrocardiographic effects of a new controlled-release form of flecainide acetate: comparison with the standard form and influence of the CYP2D6 polymorphism.
    Tennezé L; Tarral E; Ducloux N; Funck-Brentano C
    Clin Pharmacol Ther; 2002 Aug; 72(2):112-22. PubMed ID: 12189358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration.
    Marum AA; Silva BA; Bortolotto AL; Silva AC; de Antonio VZ; Belardinelli L; Verrier RL
    Int J Cardiol; 2019 Jan; 274():170-174. PubMed ID: 30217428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic atrial fibrillation in the horse with flecainide: personal observation.
    Birettoni F; Porciello F; Rishniw M; della Rocca G; Di Salvo A; Sgorbini M
    Vet Res Commun; 2007 Aug; 31 Suppl 1():273-5. PubMed ID: 17682893
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic monitoring of class I antiarrhythmic agents using high-resolution electrocardiography instead of blood samples.
    Sutovsky I; Katoh T; Takayama H; Ono T; Takano T
    Circ J; 2003 Mar; 67(3):195-8. PubMed ID: 12604865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation.
    Deneer VH; Lie-A-Huen L; Kingma JH; Proost JH; Gossen SA; Stuurman A; Uytdehaag GM; Dunselman PH; Brouwers JR
    Eur J Clin Pharmacol; 2004 Dec; 60(10):693-701. PubMed ID: 15619132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects.
    Lim KS; Cho JY; Jang IJ; Kim BH; Kim J; Jeon JY; Tae YM; Yi S; Eum S; Shin SG; Yu KS
    Br J Clin Pharmacol; 2008 Nov; 66(5):660-6. PubMed ID: 18754843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic equivalence of two flecainide acetate formulations in patients with paroxysmal atrial fibrillation by QRS analysis of ambulatory electrocardiogram.
    Coumel P; Maison-Blanche P; Tarral E; Périer A; Milliez P; Leenhardt A
    J Cardiovasc Pharmacol; 2003 May; 41(5):771-9. PubMed ID: 12717109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenously and orally administered sotalol hydrochloride in horses and effects on surface electrocardiogram and left ventricular systolic function.
    Broux B; De Clercq D; Decloedt A; De Baere S; Devreese M; Van Der Vekens N; Ven S; Croubels S; van Loon G
    Vet J; 2016 Feb; 208():60-4. PubMed ID: 26670333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.
    Lim KS; Jang IJ; Kim BH; Kim J; Jeon JY; Tae YM; Yi S; Eum S; Cho JY; Shin SG; Yu KS
    Clin Ther; 2010 Apr; 32(4):659-66. PubMed ID: 20435235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral flecainide acetate for the treatment of ventricular arrhythmias.
    Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
    N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral flecainide pharmacokinetics in patients with impaired renal function.
    Forland SC; Burgess E; Blair AD; Cutler RE; Kvam DC; Weeks CE; Fox JM; Conard GJ
    J Clin Pharmacol; 1988 Mar; 28(3):259-67. PubMed ID: 3129455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation.
    Verrier RL; Belardinelli L
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):276-283. PubMed ID: 32032206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy.
    Doki K; Homma M; Kuga K; Kawano S; Aonuma K; Yamaguchi I; Kohda Y
    J Clin Pharm Ther; 2007 Aug; 32(4):409-11. PubMed ID: 17635343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate.
    Dembek KA; Hurcombe SD; Schober KE; Toribio RE
    J Vet Emerg Crit Care (San Antonio); 2014; 24(6):759-63. PubMed ID: 25388866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.